Search Results

You searched for : LatestMercknews  

	Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus.... Jul 17
	LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer... Jun 24
	Merck to Participate in the Guggenheim Biopharma Strategy Series Merck Research Laboratories, is scheduled to participate in a virtual fireside chat at the Guggenheim Biopharma Strategy Series... Jun 19
	Merck Announces Supply Agreement with U.S. Government for Molnupiravir ... Jun 09
	U.S. FDA Accepts for Priority Review the Biologics License Application for V114 Merck announced the U.S. FDA accepted for priority review a Biologics License Application for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for ... Jan 12
	LYNPARZA (olaparib) Receives Three New Approvals in Japan LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer.... Dec 28
	Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of COVID-19 ... Dec 23
	FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA ... Dec 18
	FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA Patients with newly diagnosed esophageal and GEJ cancer face an aggressive disease with a poor prognosis, despite the currently available treatment options... Dec 17
	KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival ... Dec 16
	Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability ... Dec 11
	Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19 Meaningful new therapeutic options are desperately needed for possibly millions of people around the world who will develop severe or critical COVID-19 disease... Nov 23
	Merck Submits Applications for Licensure of V114, the Company’s Investigational 15-valent Pneumococcal Conjugate Vaccine ... Nov 23
	Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1 Collaboration with the Bill & Melinda Gates Foundation Seeks to Bring Forward a New HIV Prevention Option with Focus on Women... Nov 16
	KEYTRUDA plus LENVIMA met the trial’s primary endpoint of progression-free survival LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma... Nov 10
	LYNPARZA Approved in the EU for Treatment of BRCA1/2-Mutated Metastatic Castration-Resistant Prostate Cancer Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Agent Treatments in BRCA1/2-Mutated mCRPC... Nov 05
	Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts Merck and the MECTIZAN Donation Program, announced today a $500,000 cash donation to support NGO partners working to eliminate onchocerciasis and lymphatic filariasis... Oct 22
	Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine Pneumococcal disease in adults is on the rise globally, in part driven by disease-causing serotypes not targeted by the currently available pneumococcal conjugate vaccine... Oct 21
	FDA Approves Expanded Indication for Merck’s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL) ... Oct 15
	Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir With Doravirine for HIV-1 Merck, today announced Week 96 data from the Phase 2b trial evaluating the efficacy and safety of islatravir for HIV-1 infections... Oct 08
	Merck Animal Health Supports Rabies Elimination by 2030 on World Rabies Day Merck Animal Health announced the launch of a global campaign to raise awareness among veterinarians, dog owners and volunteers who are committed to eliminate rabies ... Sep 28
21 Matching result(s) found!

Trending Now
	Dark Web Health Data: Why Medical Records MatterOctober 27, 2026
	Can Conversational AI Improve Patient Follow-Up After Discharge?October 27, 2026
	UAE fast-tracking advanced diagnostics as global market heads for US$152 billionOctober 26, 2026
	How Digital Check-In Can Support More Accessible Patient JourneysOctober 26, 2026
	The Role of Consent Communication in Digital Healthcare ServicesOctober 26, 2026
	How Data Analytics Is Transforming Hospital Decision-MakingOctober 26, 2026
	Hospital Intelligence: The Next Big Leadership Shift in India October 26, 2026
	What Patients Should Expect From a Well-Designed Health Checkup ProgrammeOctober 23, 2026
	Building Stronger Community-Based Screening ProgrammesOctober 23, 2026
	Gulf Medical University Ranks 1st for International Student Ratio in QS Arab Region Rankings 2027October 22, 2026
	Arthritis Is Not Just an Elderly Person's Disease: Why Younger Adults Are Also Developing Joint ProblemsOctober 22, 2026
	Krishna Automotive strengthens its operations in Hyderabad. Enhances customer offering with BMW Service Workshop and BMW Premium Selection.October 22, 2026
	CTR-JK Tyre FMSCI Indian National Car Racing Championship 2026 set for season opener in CoimbatoreOctober 22, 2026
	The Anonymous Indian Charitable Trust (TAICT) Wins Sustainable Organization Award 2026October 22, 2026
	Vinod Intelligent Cookware Targets Delhi’s Premium Cookware Market with Freya Brand ActivationOctober 22, 2026
	Apollo Hospitals and Avadi Police Commissionerate Organise Health Camp for Police Personnel and Their Families Under ‘Kaval Kudumbam’ SchemeOctober 22, 2026
	TAMPOS Midterm Conference 2026 Brings Together 150 Oncologists to Advance Cancer Care Across Tamil NaduOctober 22, 2026
	Shades of Pink: Apollo Athenaa Women's Cancer Centres puts the spotlight on breast health awarenessOctober 22, 2026
	How Health Systems Can Reduce Missed Follow-UpsOctober 21, 2026
	What Good Care Coordination Looks Like Across Multiple ProvidersOctober 21, 2026